Influence of metabolic syndrome on hypertension-related target organ damage (Q46504497)

22 December 2017

title

Influence of metabolic syndrome on hypertension-related target organ damage (English)

1 reference

22 December 2017

1 reference

2

1 reference

22 December 2017

author name string

Mulè G

1

1 reference

22 December 2017

Cottone S

3

1 reference

22 December 2017

Cusimano P

4

1 reference

22 December 2017

Volpe V

5

1 reference

22 December 2017

Piazza G

6

1 reference

22 December 2017

Mongiovì R

7

1 reference

22 December 2017

Mezzatesta G

8

1 reference

22 December 2017

Andronico G

9

1 reference

22 December 2017

Cerasola G

10

1 reference

22 December 2017

language of work or name

English

0 references

publication date

1 June 2005

1 reference

22 December 2017

Journal of Internal Medicine

published in

1 reference

22 December 2017

volume

257

1 reference

22 December 2017

issue

6

1 reference

22 December 2017

page(s)

503-513

1 reference

22 December 2017

Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2005.01493.X

The dysmetabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2005.01493.X

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2005.01493.X

C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2005.01493.X

Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2005.01493.X

Prognostic value of the metabolic syndrome in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2005.01493.X

Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2005.01493.X

Effect of growth on variability of left ventricular mass: assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2005.01493.X

Comparison of cardiac structure and function in American Indians with and without the metabolic syndrome (the Strong Heart Study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2005.01493.X

Metabolic syndrome and target organ damage in untreated essential hypertensives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2005.01493.X

Circulating insulin and insulin growth factor-1 are independent determinants of left ventricular mass and geometry in essential hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2005.01493.X

The relationship of hyperinsulinemic state to left ventricular hypertrophy, microalbuminuria, and physical fitness in borderline and mild hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2005.01493.X

Insulin resistance and hyperinsulinemia: No independent relation to left ventricular mass in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2005.01493.X

Impact of glucose intolerance and insulin resistance on cardiac structure and function: sex-related differences in the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2005.01493.X

Relationships between left ventricular mass and the renin-angiotensin system, catecholamines, insulin and leptin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2005.01493.X

In vivo relationship between insulin and endothelin role of insulin-resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2005.01493.X

An overview of endothelin signaling in the cardiac myocyte

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2005.01493.X

Relation between cardiac sympathetic activity and hypertensive left ventricular hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2005.01493.X

Physiology and pathophysiology of the adipose tissue renin-angiotensin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2005.01493.X

The obesity-associated peptide leptin induces hypertrophy in neonatal rat ventricular myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2005.01493.X

Disruption of leptin signaling contributes to cardiac hypertrophy independently of body weight in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2005.01493.X

Plasma leptin level is associated with myocardial wall thickness in hypertensive insulin-resistant men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2005.01493.X

Association between microalbuminuria and the metabolic syndrome: NHANES III

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2005.01493.X

Insulin, sodium-lithium countertransport, and microalbuminuria in hypertensive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2005.01493.X

Insulin resistance in microalbuminuric hypertension. Sites and mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2005.01493.X

Risk variables of insulin resistance syndrome in African-American and Caucasian young adults with microalbuminuria: the Bogalusa Heart Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2005.01493.X

Microalbuminuria is strongly associated with NIDDM and hypertension, but not with the insulin resistance syndrome: the Hoorn Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2005.01493.X

Prognostic implications of left ventricular hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2005.01493.X

Microalbuminuria and cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2005.01493.X

Associations between the metabolic syndrome and retinal microvascular signs: the Atherosclerosis Risk In Communities study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2005.01493.X

21 January 2018

Hypertensive retinopathy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2005.01493.X

Prevalence of the metabolic syndrome among the Inuit in Greenland. A comparison between two proposed definitions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2005.01493.X

Prevalence of metabolic syndrome in an Indian urban population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2005.01493.X

Insulin resistance and cardiovascular complications in patients with essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2005.01493.X

10.1111/J.1365-2796.2005.01493.X

21 January 2018

Identifiers

DOI

1 reference

22 December 2017

PubMed ID

15910554

1 reference

22 December 2017